Applied Health Economics and Health Policy This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Willingness to Pay for a COVID-19 Vaccine
ConclusionsThe high WTP value creates an opportunity for formulating public health policy. The results of this study suggest that governments can provide the vaccine free to low-income groups and allow those with higher incomes to acquire the vaccine through the private sector by paying. This will be useful especially for countries with economic difficulties. (Source: Applied Health Economics and Health Policy)
Source: Applied Health Economics and Health Policy - February 23, 2021 Category: Health Management Source Type: research

Disease-Specific Out-of-Pocket Payments, Catastrophic Health Expenditure and Impoverishment Effects in India: An Analysis of National Health Survey Data
ConclusionOur study suggests that there is an urgent need for political players and policymakers to design health system financing policies and strict implementation that will provide financial risk protection to households in India. (Source: Applied Health Economics and Health Policy)
Source: Applied Health Economics and Health Policy - February 22, 2021 Category: Health Management Source Type: research

Costs of Illness of Spinal Muscular Atrophy: A Systematic Review
ConclusionsThe current body of evidence of costs of illness of SMA is relatively scarce and characterized by considerable variability across geographical settings and disease phenotypes. Our review provides data pertaining to the economic impact of SMA, which is of particular relevance in light of emerging treatments and ongoing research in this field, and underscores the substantial unmet medical need in this patient population. (Source: Applied Health Economics and Health Policy)
Source: Applied Health Economics and Health Policy - February 12, 2021 Category: Health Management Source Type: research

Economic Analyses of Pathogen-Reduction Technologies in Blood Transfusion: A Systematic Literature Review
ConclusionsOverall, the results of economic evaluations of bacterial risk-control strategies, regardless of mechanism, were highly dependent on the current screening protocols in place. The optimization of blood transfusion safety may not result in decisions made at the willingness-to-pay thresholds commonly seen in pharmaceutical evaluations. Given the critical public health role of blood products, and the potential safety benefits introduced by advancements, it is important to continue building this body of evidence with more transparency and data source heterogeneity. This updated literature review provides global conte...
Source: Applied Health Economics and Health Policy - February 8, 2021 Category: Health Management Source Type: research

The Danish EQ-5D-5L Value Set: A Hybrid Model Using cTTO and DCE Data
ConclusionsThis study established the Danish EQ-5D-5L value set, which represents the preferences of the Danish general population, and is expected to provide key input for healthcare decision-making in a Danish context. (Source: Applied Health Economics and Health Policy)
Source: Applied Health Economics and Health Policy - February 2, 2021 Category: Health Management Source Type: research

Does Biosimilar Bevacizumab Offer Affordable Treatment Options for Cancer Patients in the USA? A Budget Impact Analysis from US Commercial and Medicare Payer Perspectives
ConclusionsThe introduction of biosimilar bevacizumab-bvzr was estimated to provide substantial cost savings for US payers, which would allow additional patients access to bevacizumab treatment. (Source: Applied Health Economics and Health Policy)
Source: Applied Health Economics and Health Policy - January 28, 2021 Category: Health Management Source Type: research

The Budget Impact of Monoclonal Antibodies Used to Treat Metastatic Colorectal Cancer in Minas Gerais, Brazil
ConclusionThese results highlight the appreciable costs for incorporating bevacizumab, cetuximab, and panitumumab into the SUS. Appreciable discounts are likely to be necessary before incorporation of these mAbs is approved. (Source: Applied Health Economics and Health Policy)
Source: Applied Health Economics and Health Policy - January 28, 2021 Category: Health Management Source Type: research

Cost of Medicare for All: Review of the Estimates
AbstractThis paper critically evaluates the estimates of the cost of Medicare for All (M4A) in the USA. Six studies that estimate the 1-year total cost of M4A in the USA are reviewed. These studies find that M4A would increase national health spending by as much as 16.9% or decrease it by 20.0%, representing a range of estimates that generates uncertainty and confusion regarding what to expect if M4A were implemented. To develop more comparable estimates, the national health spending in each study ’s comparison year is used as the baseline. Estimates of the change in national health spending under M4A for each report are...
Source: Applied Health Economics and Health Policy - January 25, 2021 Category: Health Management Source Type: research

Opioid Prescribing in Canada following the Legalization of Cannabis: A Clinical and Economic Time-Series Analysis
ConclusionsOur findings support the hypothesis that easier access to cannabis for pain may reduce opioid use for both public and private drug plans. (Source: Applied Health Economics and Health Policy)
Source: Applied Health Economics and Health Policy - January 25, 2021 Category: Health Management Source Type: research

The Vatican City State Internal Healthcare System Response to COVID-19 Pandemic: Prevention and Control Strategies
(Source: Applied Health Economics and Health Policy)
Source: Applied Health Economics and Health Policy - January 20, 2021 Category: Health Management Source Type: research

Translating Research to Policy: Setting Provider Payment Rates for Strategic Purchasing under India's National Publicly Financed Health Insurance Scheme
AbstractBackgroundIn 2018, the Government of India launchedAyushman Bharat Pradhan Mantri-Jan Aarogya Yojana (AB PM-JAY), a large tax-funded health insurance scheme. In this paper, we present findings of the Costing of Health Services in India (CHSI) study, describe the process of use of cost evidence for price-setting under AB PM-JAY, and estimate its fiscal impact.MethodsReference costs were generated from the first phase of CHSI study, which sampled 11 tertiary public hospitals from 11 Indian states. Cost for Health Benefit Packages (HBPs) was estimated using mixed (top-down and bottom-up) micro-costing methods. The pro...
Source: Applied Health Economics and Health Policy - January 19, 2021 Category: Health Management Source Type: research

How Many Intensive Care Beds are Justifiable for Hospital Pandemic Preparedness? A Cost-effectiveness Analysis for COVID-19 in Germany
ConclusionsThis article demonstrates the applicability of cost-effectiveness analysis to policies of hospital pandemic preparedness and response capacity strengthening. In Germany, the provision of a staffed ICU bed reserve capacity appears to be cost-effective even for a low probability of bed utilization. (Source: Applied Health Economics and Health Policy)
Source: Applied Health Economics and Health Policy - January 12, 2021 Category: Health Management Source Type: research

Which Criteria are Considered and How are They Evaluated in Health Technology Assessments? A Review of Methodological Guidelines Used in Western and Asian Countries
ConclusionsSubstantial convergence is seen in the criteria included in the HTA process, as well as the methods to evaluate and quantify them. Further efforts are needed to verify whether the criteria identified from the guidelines are incorporated in real HTA decisions, and how they are assessed and weighted in practice. (Source: Applied Health Economics and Health Policy)
Source: Applied Health Economics and Health Policy - January 11, 2021 Category: Health Management Source Type: research

Copula Models for Addressing Sample Selection in the Evaluation of Public Health Programmes: An Application to the Leeds Let ’s Get Active Study
AbstractSample selectivity is a recurrent problem in public health programmes and poses serious challenges to their evaluation. Traditional approaches to handle sample selection tend to rely on restrictive assumptions. The aim of this paper is to illustrate a copula-based selection model to handle sample selection in the evaluation of public health programmes. Motivated by a public health programme to promote physical activity in Leeds (England), we describe the assumptions underlying the copula selection, and its relative advantages compared with commonly used approaches to handle sample selection, such as inverse probabi...
Source: Applied Health Economics and Health Policy - January 11, 2021 Category: Health Management Source Type: research

Cost-Effectiveness Analysis of Parenteral Methotrexate for the Treatment of Crohn ’s Disease
ConclusionParenteral MTX proved to be cost-effective in patients with mild-to-moderate CD. This is the first published cost-effectiveness analysis of pMTX for this indication. It also shows an example of a lack of valuation of generic therapy despite its cost-effectiveness and a clear benefit to the healthcare system. (Source: Applied Health Economics and Health Policy)
Source: Applied Health Economics and Health Policy - January 11, 2021 Category: Health Management Source Type: research